Envoy Medical Inc.

NASDAQ: COCH · Real-Time Price · USD
1.45
-0.03 (-2.03%)
At close: Aug 15, 2025, 9:54 AM

Envoy Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-20.8M -29.91M -15.92M -8.68M
Depreciation & Amortization
173K 133K 75K 71K
Stock-Based Compensation
562K n/a n/a n/a
Other Working Capital
333K -1.51M -355K -345K
Other Non-Cash Items
2.75M 13.63M 7.2M 1.75M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-638K -1.51M -160K -82K
Operating Cash Flow
-17.95M -17.65M -8.8M -6.94M
Capital Expenditures
-980K -153K -218K -125K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -425M
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 425M
Investing Cash Flow
-980K -153K -218K -125K
Debt Repayment
20M 10M 8M 8M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-2.45M n/a n/a n/a
Other Financial Acitivies
899K n/a n/a -428.31M
Financial Cash Flow
20.2M 21.84M 8.09M 8.06M
Net Cash Flow
1.26M 4.04M -938K 987K
Free Cash Flow
-18.93M -17.81M -9.02M -7.06M